JP2015524813A - タカサゴサンシチソウの肝炎を治療する薬物又は保健用食品の製造への応用 - Google Patents
タカサゴサンシチソウの肝炎を治療する薬物又は保健用食品の製造への応用 Download PDFInfo
- Publication number
- JP2015524813A JP2015524813A JP2015524634A JP2015524634A JP2015524813A JP 2015524813 A JP2015524813 A JP 2015524813A JP 2015524634 A JP2015524634 A JP 2015524634A JP 2015524634 A JP2015524634 A JP 2015524634A JP 2015524813 A JP2015524813 A JP 2015524813A
- Authority
- JP
- Japan
- Prior art keywords
- takasago
- extract
- water
- sanshichiso
- application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 16
- 239000003814 drug Substances 0.000 title claims abstract description 15
- 229940079593 drug Drugs 0.000 title claims abstract description 8
- 231100000283 hepatitis Toxicity 0.000 title claims abstract description 7
- 208000006454 hepatitis Diseases 0.000 title claims abstract description 7
- 235000013305 food Nutrition 0.000 title claims abstract description 4
- 239000000284 extract Substances 0.000 claims abstract description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 32
- 239000000469 ethanolic extract Substances 0.000 claims abstract description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 29
- 239000008187 granular material Substances 0.000 claims description 11
- 238000000605 extraction Methods 0.000 claims description 10
- 239000002775 capsule Substances 0.000 claims description 6
- 235000013402 health food Nutrition 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 238000009472 formulation Methods 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 4
- 229940100688 oral solution Drugs 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 230000017074 necrotic cell death Effects 0.000 abstract description 10
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract description 8
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 abstract description 8
- 108090000340 Transaminases Proteins 0.000 abstract description 8
- 102000003929 Transaminases Human genes 0.000 abstract description 8
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 abstract description 8
- 230000002829 reductive effect Effects 0.000 abstract description 8
- 210000002966 serum Anatomy 0.000 abstract description 8
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 abstract description 8
- 229930195712 glutamate Natural products 0.000 abstract description 7
- 230000007850 degeneration Effects 0.000 abstract description 6
- 206010067125 Liver injury Diseases 0.000 abstract description 4
- 239000000843 powder Substances 0.000 description 12
- 241001465754 Metazoa Species 0.000 description 10
- 210000004209 hair Anatomy 0.000 description 8
- 210000003494 hepatocyte Anatomy 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 6
- 210000003462 vein Anatomy 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- JMZOMFYRADAWOG-UHFFFAOYSA-N methyl 7-methoxy-4-(7-methoxy-5-methoxycarbonyl-1,3-benzodioxol-4-yl)-1,3-benzodioxole-5-carboxylate Chemical compound COC(=O)C1=CC(OC)=C2OCOC2=C1C1=C2OCOC2=C(OC)C=C1C(=O)OC JMZOMFYRADAWOG-UHFFFAOYSA-N 0.000 description 5
- 229920001353 Dextrin Polymers 0.000 description 4
- 239000004375 Dextrin Substances 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 235000019425 dextrin Nutrition 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000002440 hepatic effect Effects 0.000 description 4
- 230000008595 infiltration Effects 0.000 description 4
- 238000001764 infiltration Methods 0.000 description 4
- 210000004969 inflammatory cell Anatomy 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 210000005228 liver tissue Anatomy 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 3
- 235000019658 bitter taste Nutrition 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 238000002481 ethanol extraction Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 238000003809 water extraction Methods 0.000 description 3
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 2
- 108010082126 Alanine transaminase Proteins 0.000 description 2
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 2
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 2
- KVSNMTUIMXZPLU-UHFFFAOYSA-N D:A-friedo-oleanane Natural products CC12CCC3(C)C4CC(C)(C)CCC4(C)CCC3(C)C2CCC2(C)C1CCCC2C KVSNMTUIMXZPLU-UHFFFAOYSA-N 0.000 description 2
- JUUHNUPNMCGYDT-UHFFFAOYSA-N Friedelin Natural products CC1CC2C(C)(CCC3(C)C4CC(C)(C)CCC4(C)CCC23C)C5CCC(=O)C(C)C15 JUUHNUPNMCGYDT-UHFFFAOYSA-N 0.000 description 2
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 241001521797 Scorpaena notata Species 0.000 description 2
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 2
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 2
- OFMXGFHWLZPCFL-SVRPQWSVSA-N friedelin Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3CCC(=O)[C@@H]1C OFMXGFHWLZPCFL-SVRPQWSVSA-N 0.000 description 2
- MFVJCHSUSSRHRH-UHFFFAOYSA-N friedeline Natural products CC1(C)CCC2(C)CCC3C4(C)CCC5C(C)(C)C(=O)CCC5(C)C4CCC3(C)C2C1 MFVJCHSUSSRHRH-UHFFFAOYSA-N 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- CBFCDTFDPHXCNY-UHFFFAOYSA-N icosane Chemical compound CCCCCCCCCCCCCCCCCCCC CBFCDTFDPHXCNY-UHFFFAOYSA-N 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- CNNRPFQICPFDPO-UHFFFAOYSA-N octacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCO CNNRPFQICPFDPO-UHFFFAOYSA-N 0.000 description 2
- UTOPWMOLSKOLTQ-UHFFFAOYSA-N octacosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O UTOPWMOLSKOLTQ-UHFFFAOYSA-N 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229950005143 sitosterol Drugs 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 2
- 229940032091 stigmasterol Drugs 0.000 description 2
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 2
- 235000016831 stigmasterol Nutrition 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- TYWMIZZBOVGFOV-UHFFFAOYSA-N tetracosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCO TYWMIZZBOVGFOV-UHFFFAOYSA-N 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 229960002666 1-octacosanol Drugs 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 241001573881 Corolla Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010011985 Decubitus ulcer Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 241001558017 Gynura Species 0.000 description 1
- 244000045531 Gynura pseudochina Species 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 240000000543 Pentas lanceolata Species 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- VWDLOXMZIGUBKM-AMHNIKBJSA-N Stigmasterol-3-O-beta-D-glucopyranoside Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@@H]4[C@@](C)([C@@H]([C@@H](/C=C/[C@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 VWDLOXMZIGUBKM-AMHNIKBJSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 238000013245 carbon tetrachloride model Methods 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- SEACYXSIPDVVMV-UHFFFAOYSA-L eosin Y Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 SEACYXSIPDVVMV-UHFFFAOYSA-L 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000003777 experimental drug Substances 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- VAMFXQBUQXONLZ-UHFFFAOYSA-N n-alpha-eicosene Natural products CCCCCCCCCCCCCCCCCCC=C VAMFXQBUQXONLZ-UHFFFAOYSA-N 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000009543 pathological alteration Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 210000003660 reticulum Anatomy 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 230000007863 steatosis Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- VWDLOXMZIGUBKM-AUGXRQBFSA-N stigmasterol 3-O-beta-D-glucoside Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VWDLOXMZIGUBKM-AUGXRQBFSA-N 0.000 description 1
- VWDLOXMZIGUBKM-OFUAXYCQSA-N stigmasterol-3-yl-O-beta-D-glucopyranoside Natural products CC[C@H](C=C[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C VWDLOXMZIGUBKM-OFUAXYCQSA-N 0.000 description 1
- VWDLOXMZIGUBKM-UHFFFAOYSA-N stigmasterol-3beta-O-D-glucoside Natural products C1CC2(C)C3CCC4(C)C(C(C)C=CC(CC)C(C)C)CCC4C3CC=C2CC1OC1OC(CO)C(O)C(O)C1O VWDLOXMZIGUBKM-UHFFFAOYSA-N 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 150000008505 β-D-glucopyranosides Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Alternative & Traditional Medicine (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310179552.9A CN103222995B (zh) | 2013-05-15 | 2013-05-15 | 白子菜在制备护肝药物或保健食品中的应用 |
| CN201310179552.9 | 2013-05-15 | ||
| PCT/CN2014/076376 WO2014183551A1 (zh) | 2013-05-15 | 2014-04-28 | 白子菜在制备治疗肝炎的药物或保健食品中的应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2015524813A true JP2015524813A (ja) | 2015-08-27 |
Family
ID=48833791
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015524634A Pending JP2015524813A (ja) | 2013-05-15 | 2014-04-28 | タカサゴサンシチソウの肝炎を治療する薬物又は保健用食品の製造への応用 |
Country Status (7)
| Country | Link |
|---|---|
| JP (1) | JP2015524813A (zh) |
| KR (1) | KR20150036538A (zh) |
| CN (1) | CN103222995B (zh) |
| GB (1) | GB2522146B (zh) |
| HK (1) | HK1212589A1 (zh) |
| SG (1) | SG11201501648SA (zh) |
| WO (1) | WO2014183551A1 (zh) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103222995B (zh) * | 2013-05-15 | 2014-09-03 | 李伟权 | 白子菜在制备护肝药物或保健食品中的应用 |
| CN103230444B (zh) * | 2013-05-15 | 2014-03-19 | 李伟权 | 一种降脂护肝中药组合物及其制备方法和应用 |
| CN110368411B (zh) * | 2019-08-02 | 2021-08-06 | 龙岩学院 | 一种白背天葵多酚的提取工艺及其分离纯化方法 |
| CN112655601A (zh) * | 2020-12-02 | 2021-04-16 | 中国水产科学研究院淡水渔业研究中心 | 一种四氯化碳诱导淡水鱼急性肝肠联合损伤模型的建立及其应用 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10251154A (ja) * | 1997-03-13 | 1998-09-22 | Suntory Ltd | 肝炎抑制組成物 |
| JP2007519715A (ja) * | 2004-01-31 | 2007-07-19 | キョン キム | ケンボナシ抽出物、ダンコウバイ抽出物、またはその混合生薬抽出物を有効成分として含む組成物 |
| JP2008074807A (ja) * | 2006-09-25 | 2008-04-03 | Oriza Yuka Kk | 肝保護剤 |
| CN101485706A (zh) * | 2008-01-19 | 2009-07-22 | 郑乐建 | 抗氧化自由基祛面斑作用的白背三七及其软胶囊制剂 |
| JP2010155789A (ja) * | 2008-12-26 | 2010-07-15 | Yakult Honsha Co Ltd | 肝機能障害改善剤 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102631391A (zh) * | 2012-05-15 | 2012-08-15 | 李伟权 | 白子菜在制备降脂药物或保健食品中的应用 |
| CN103222995B (zh) * | 2013-05-15 | 2014-09-03 | 李伟权 | 白子菜在制备护肝药物或保健食品中的应用 |
-
2013
- 2013-05-15 CN CN201310179552.9A patent/CN103222995B/zh active Active
-
2014
- 2014-04-28 KR KR1020157003623A patent/KR20150036538A/ko not_active Application Discontinuation
- 2014-04-28 SG SG11201501648SA patent/SG11201501648SA/en unknown
- 2014-04-28 GB GB1507323.2A patent/GB2522146B/en active Active
- 2014-04-28 WO PCT/CN2014/076376 patent/WO2014183551A1/zh active Application Filing
- 2014-04-28 JP JP2015524634A patent/JP2015524813A/ja active Pending
-
2016
- 2016-01-15 HK HK16100444.4A patent/HK1212589A1/zh unknown
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10251154A (ja) * | 1997-03-13 | 1998-09-22 | Suntory Ltd | 肝炎抑制組成物 |
| JP2007519715A (ja) * | 2004-01-31 | 2007-07-19 | キョン キム | ケンボナシ抽出物、ダンコウバイ抽出物、またはその混合生薬抽出物を有効成分として含む組成物 |
| JP2008074807A (ja) * | 2006-09-25 | 2008-04-03 | Oriza Yuka Kk | 肝保護剤 |
| CN101485706A (zh) * | 2008-01-19 | 2009-07-22 | 郑乐建 | 抗氧化自由基祛面斑作用的白背三七及其软胶囊制剂 |
| JP2010155789A (ja) * | 2008-12-26 | 2010-07-15 | Yakult Honsha Co Ltd | 肝機能障害改善剤 |
Non-Patent Citations (1)
| Title |
|---|
| JPN6015048065; Ｐｈａｒｍａｃｏｇｎ Ｍａｇ． Ｖｏｌ．７， Ｎｏ．２５, 2011, ｐ．４０-４５ * |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2522146A (en) | 2015-07-15 |
| GB201507323D0 (en) | 2015-06-10 |
| HK1212589A1 (zh) | 2016-06-17 |
| WO2014183551A1 (zh) | 2014-11-20 |
| CN103222995A (zh) | 2013-07-31 |
| GB2522146B (en) | 2016-02-10 |
| KR20150036538A (ko) | 2015-04-07 |
| SG11201501648SA (en) | 2016-01-28 |
| CN103222995B (zh) | 2014-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ganesh et al. | Phytochemical analysis of Acanthus ilicifolius and Avicennia officinalis by GC-MS | |
| CN110519997B (zh) | 通过辣木叶提取物和杜仲提取物的复合物的抗生、抗氧化、抗炎、抑制牙周骨损失和再生牙周骨缓解牙龈炎和牙周炎的方法 | |
| CN106344648B (zh) | 一种百里香属植物、提取物及其应用 | |
| JP2015524813A (ja) | タカサゴサンシチソウの肝炎を治療する薬物又は保健用食品の製造への応用 | |
| KR101794006B1 (ko) | 식물 추출물을 포함하는 염증 개선용 조성물 | |
| KR20180130080A (ko) | 자초 추출물을 포함하는 항염용 조성물 및 이의 제조방법 | |
| CN106668348A (zh) | 用于治疗糖尿病视网膜病变的药物组合物 | |
| KR101768612B1 (ko) | 간기능 개선 효과를 갖는 식품용 조성물 및 이를 이용한 건강차의 제조방법 | |
| KR101615923B1 (ko) | 거북꼬리, 바디나물 및 우엉의 복합추출물을 함유하는 항피부알러지 또는 항염증용 조성물 | |
| CN112336764A (zh) | 一种抗氧化和增强免疫力的中药组合物及其制备方法和应用 | |
| KR101846493B1 (ko) | 식물의 추출 복합물을 포함하는 항염 조성물 및 염증성 질환 치료용 조성물 | |
| CN104524139A (zh) | 多星韭提取物及其用途 | |
| Gadekar et al. | On Cucumis callocus | |
| CN106727861A (zh) | 一种治疗腮腺炎的药物组合物及其制备方法 | |
| KR102617383B1 (ko) | 석류, 마 및 둥굴레의 혼합 추출물을 이용한 항비만용 조성물 및 그 제조방법 | |
| WO2010128949A1 (en) | A nutraceutical composition | |
| KR20120000243A (ko) | 일본목련 열매 추출물을 포함하는 항암제 조성물 | |
| KR101855820B1 (ko) | 간 기능 개선 및 스태미나 증진을 위한 건강식품 조성물 | |
| CN105031286A (zh) | 一种治疗缺铁性贫血的中药制剂及其制备方法 | |
| CN104940428A (zh) | 一种含有枸杞子的降血糖组合物及其用途 | |
| KR20160030726A (ko) | 간기능 개선 효과를 갖는 식품용 조성물 및 이를 이용한 건강차의 제조방법 | |
| KR20230118417A (ko) | 바이러스 원인, 사구체신염 및 신장염 치료 | |
| CN102764349B (zh) | 红葱根在制备保护胃黏膜的药物中的应用 | |
| JP5909272B2 (ja) | シマオオタニワタリの抽出物の製造方法 | |
| Thazar et al. | Pharmacognostic Study on the Raw Materials Present In Some Medicinal Plants and Their Antimalarial Effect |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20151201 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20160531 |